MedPath

Adductor Canal Block (ACB) Versus ACB /Saphenous Block in Patients Undergoing Anterior Cruciate Ligament Repair

Not Applicable
Conditions
Postoperative Pain
Interventions
Procedure: Ultrasound Guided Adductor Canal Block
Procedure: General anesthesia
Procedure: Ultrasound Guided Saphenous Nerve Block
Registration Number
NCT04443634
Lead Sponsor
Cairo University
Brief Summary

Knee surgeries are associated with severe postoperative pain. Blocking the femoral nerve (or saphenous nerve) in the adductor canal is increasingly used for knee analgesia. It carries potential benefits that encourage anesthesiologists to do it. It has a motor sparing property. Injection of local anesthetics in this lengthy canal that contains a variable amount of connective or fibrous tissue might lead to a patchy distribution of local anesthetics. Thus, the possibility of incomplete block of the saphenous nerve (most important nerve in knee innervations) cannot be excluded.

Detailed Description

Aim of the study is to compare the efficacy of the adductor canal block to the combined adductor canal block and saphenous nerve block at the distal third of thigh in the intermuscular plane between Vastus Medialis and Sartorius muscles in pain relief following knee arthroscopic anterior cruciate ligament repair.

After written informed consent, patients will be randomized in three groups:

Group (Adductor 20): Ultrasound guided adductor canal block will be performed with injection of 20 ml bupivcaine 0.5%.

Group (Adductor 30) Ultrasound guided adductor canal block will be performed with injection of 30 ml bupivacaine 0.5%. Group (Adductor/saphenous ): Ultrasound guided adductor canal block will be performed by injection of 20 ml bupivacaine 0.5%, combined with ultrasound guided saphenous

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
88
Inclusion Criteria
  • Scheduled for knee orthopedic ( ACL repair)
  • Physical status ASA I, II.
  • Body mass index (BMI): > 20 kg/m2 and < 35 kg/m2.
Exclusion Criteria
  • • Patients with known sensitivity or contraindication to drug used in the study (local anesthetics, opioids).

    • History of psychological disorders and/or chronic pain.
    • Contraindication to regional anesthesia e.g. local sepsis, pre- existing peripheral neuropathies and coagulopathy.
    • Infection of the skin at the site of needle puncture area.
    • Patient refusal.
    • Severe respiratory or cardiac disorders.
    • Advanced liver or kidney disease.
    • Pregnancy.
    • Patient with surgery duration more than two hours.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Adductor 20Bupivacaine 20 mlUltrasound guided adductor canal block will be performed with injection of 20 ml bupivacaine
Adductor 20Ultrasound Guided Adductor Canal BlockUltrasound guided adductor canal block will be performed with injection of 20 ml bupivacaine
Adductor 20General anesthesiaUltrasound guided adductor canal block will be performed with injection of 20 ml bupivacaine
Adductor 30Ultrasound Guided Adductor Canal BlockUltrasound guided adductor canal block will be performed with injection of 30ml bupivacaine
Adductor 30General anesthesiaUltrasound guided adductor canal block will be performed with injection of 30ml bupivacaine
Adductor 30Bupivacaine 30mlUltrasound guided adductor canal block will be performed with injection of 30ml bupivacaine
Adductor /SaphenousUltrasound Guided Adductor Canal BlockUltrasound guided adductor canal block will be performed by injection of 20 ml bupivacaine , combined with ultrasound guided saphenous nerve block at the distal third of the thigh in the intermuscular plane between Vastus Medialis and Sartorius muscle with injection of 10ml bupivacaine 0.5%.
Adductor /SaphenousUltrasound Guided Saphenous Nerve BlockUltrasound guided adductor canal block will be performed by injection of 20 ml bupivacaine , combined with ultrasound guided saphenous nerve block at the distal third of the thigh in the intermuscular plane between Vastus Medialis and Sartorius muscle with injection of 10ml bupivacaine 0.5%.
Adductor /SaphenousGeneral anesthesiaUltrasound guided adductor canal block will be performed by injection of 20 ml bupivacaine , combined with ultrasound guided saphenous nerve block at the distal third of the thigh in the intermuscular plane between Vastus Medialis and Sartorius muscle with injection of 10ml bupivacaine 0.5%.
Adductor /SaphenousBupivacaine 20 mlUltrasound guided adductor canal block will be performed by injection of 20 ml bupivacaine , combined with ultrasound guided saphenous nerve block at the distal third of the thigh in the intermuscular plane between Vastus Medialis and Sartorius muscle with injection of 10ml bupivacaine 0.5%.
Adductor /SaphenousBupivacaine 10mlUltrasound guided adductor canal block will be performed by injection of 20 ml bupivacaine , combined with ultrasound guided saphenous nerve block at the distal third of the thigh in the intermuscular plane between Vastus Medialis and Sartorius muscle with injection of 10ml bupivacaine 0.5%.
Primary Outcome Measures
NameTimeMethod
The total dose of morphine consumption in the first 24 hours postoperatively.24 hours postoperative

The total amount of morphine consumption in the first 24 hours postoperatively.

Secondary Outcome Measures
NameTimeMethod
Failure rate of the block24 hours

• Failure rate of the block will be calculated, where the block will be considered a failed block if the patient requires more than two doses of rescue analgesia in the first hour postoperatively.

Block related complications1 mounth

o The incidence of vascular puncture, and presence or absence of saphenous nerve neuritis during the first month after surgery were also recorded

Total dose of intraoperative fentanyle adminstration2 hours intraoperatively
Numeric Pain Rating Scale24 hours postoperative

Numeric Pain Rating Scale, both at rest and during movement: 30 minutes,2, 4,6, 8, 12, 16, 20 and 24 hours postoperatively. It is labeled from zero to ten, with zero being an example of someone with no pain and ten being the worst pain possible.

Trial Locations

Locations (1)

Anesthesia Department

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath